FFA
FOLD

Farther Finance Advisors’s Amicus Therapeutics FOLD Stock Holding History

Farther Finance Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,930
Closed -$27.9K – 6033
2026
Q1 		$27.9K Buy
1,930
+59
+3% +$846 ﹤0.01% 3420
2025
Q4 		$26.6K Buy
1,871
+1,803
+2,651% +$17.7K ﹤0.01% 3244
2025
Q3 		$536 Buy
68
+36
+113% +$256 ﹤0.01% 4525
2025
Q2 		$183 Sell
32
-44
-58% -$284 ﹤0.01% 4223
2025
Q1 		$604 Sell
76
-5
-6% -$46 ﹤0.01% 3741
2024
Q4 		$763 Sell
81
-25
-24% -$260 ﹤0.01% 3334
2024
Q3 		$1.13K Hold
106
– – ﹤0.01% 3205
2024
Q2 		$1.04K Sell
106
-155
-59% -$1.59K ﹤0.01% 3068
2024
Q1 		$3.07K Buy
261
+5
+2% +$64 ﹤0.01% 2306
2023
Q4 		$3.63K Buy
256
+226
+753% +$2.57K ﹤0.01% 2134
2023
Q3 		$365 Buy
+30
New +$387 ﹤0.01% 2342

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Farther Finance Advisors's FOLD Position: Q2 2026 in Review

Farther Finance Advisors sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 1,930 shares — an estimated $27.9K sold.

Farther Finance Advisors first reported a position in FOLD in Q3 2023 and held it in 11 quarters. The position peaked at $27.9K in Q1 2026. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

  • Farther Finance Advisors reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Farther Finance Advisors sold 1,930 Amicus Therapeutics shares in Q2 2026, an estimated $27.9K.
  • Farther Finance Advisors first reported a position in Amicus Therapeutics in Q3 2023 and held it in 11 quarters.
  • Farther Finance Advisors's Amicus Therapeutics position peaked at $27.9K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.